Vincent Lin

Vincent Lin is a highly experienced professional in global market access and health economics, currently serving as the Global Value and Access Lead for Shionogi Inc. since June 2023, where responsibilities include leading global market access and pricing strategies for early pipeline candidates in oncology, neurology, virology, and obesity. Previously, Vincent held the position of Senior Director of Global Market Access at Autolus Ltd. from March 2020 to January 2023, focusing on the global value and reimbursement strategy for Obe-cel. Prior to that, Vincent was Director of Europe HTA at Kite Pharma, overseeing all HTA activities in the EU region, and also contributed as Associate Director of Health Economics and Outcomes Research, launching Yescarta, the first CAR T therapy for adult malignancy. Earlier roles include market access and health economics positions at Amgen and Baxter Healthcare. Vincent holds an MS in Pharmaceutical Outcomes Research and Policy from the University of Washington, a Pharm.D. from Touro University California, and a BS in Biology from UC Irvine.